Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat

@article{UvnsMoberg1996EffectsO5,
  title={Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat},
  author={K. Uvn{\"a}s-Moberg and V. Hillegaart and P. Alster and S. Ahl{\'e}nius},
  journal={Neuropharmacology},
  year={1996},
  volume={35},
  pages={1635-1640}
}
Adult male Sprague-Dawley rats were administered the 5-HT subtype selective receptor agonists 8-OH-DPAT (0.5-2.0 mg/kg), buspirone (2-8 mg/kg) (5-HT1A), TFMPP (0.125-2.0 mg/kg) (5-HT1B), DOI (0.125-2.0 mg/kg) (5-HT2A) and m-CPBG (1.25-20.0 mg/kg) (5-HT3), subcutaneously. Oxytocin, cholecystokinin (CCK), somatostatin and gastrin plasma levels were determined by standard RIA techniques 30 and 120 min after injection of the respective 5-HT receptor agonist. It was found that the 5-HT1A and the 5… Expand
On a possible dual role for the lateral septal area 5-HT1A receptor system in the regulation of water intake and urinary excretion
TLDR
It is demonstrated that the responsiveness of the 5-HT(1A) receptor system in the LSA can be enhanced or depressed as a consequence of an induced rise in extracellular sodium. Expand
Serotonergic involvement in stress-induced vasopressin and oxytocin secretion.
TLDR
5-HT(2A), 5- HT(2C) and possibly 5-HT (3) and 5-ht(4) receptors, but not 5-hydroxytryptamine(1A) receptor, are involved in the restraint stress-induced AVP secretion and the dehydration and hemorrhage-induced OT responses are at least mediated by the 5-Hat (2A) and 2C receptors. Expand
Studies on the neuroendocrine role of serotonin.
TLDR
Investigating in male Wistar rats, the involvement of serotonin (5-HT) and 5-HT receptors in the regulation of the gene expression of hypothalamic hormones and in the secretion of the pituitary gland hormones prolactin, adrenocorticotropic hormone (ACTH), vasopressin (AVP) and oxytocin in basal and stress conditions found CRH was found to have a major role but not a complete responsibility. Expand
SB 242084: A Selective 5‐HT2C Receptor Antagonist
TLDR
In vivo studies have shown that SB 242084 is a very effective antagonist of behavioral responses mediated by 5-HT2C receptors such as penile erections, and the hypophagic and hypolocomotor effect of mCPP in rats, and this compound has anxiolytic-like properties. Expand
SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system
TLDR
Data indicate that the central 5- HT system exerts a tonic and phasic inhibitory control on mesolimbic DA neuron activity and that 5-HT2C receptor subtypes are involved in this effect. Expand
Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides
The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male WistarExpand
Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study
TLDR
Data indicate that mCPP and MK 212 selectively inhibit mesolimbic dopaminergic function by acting on 5‐HT2C receptors, and might be useful in clinical conditions where it is necessary to reduce the meslimbic dopamine activity without affecting the nigrostriatal function. Expand
Serotonin Receptors Involved in Vasopressin and Oxytocin Secretion
TLDR
5‐HT‐induced vasopressin secretion primarily is mediated via 5‐HT2C, 4‐HT4 and 5‐ HT7 receptors, whereas 5-HT2A, 5‐ht3 and 5­HT5A receptors seem to be of minor importance. Expand
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
TLDR
Taking together, neurochemical approaches using microdialysis can not only contribute to clarification of the physiological role of the serotonergic neuronal systems but may also be a powerful pharmacological approach for the development of therapeutic strategies to the treatment of depression, schizophrenia, Parkinson's disease and drug abuse. Expand
The 5-HT2C Receptor Subtype Controls Central Dopaminergic Systems: Evidence from Electrophysiological and Neurochemical Studies
TLDR
This chapter was undertaken to summarize the authors’ and others’ works that have extensively explored the role of 5-HT2C receptors in the control of DA systems both in basal and drug-induced conditions, using in vivo electrophysiological and microdialytic techniques. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat
TLDR
The results suggest that 5- HT1A and 5-HT2/5-HT1C receptors all stimulate oxytocin secretion, and this effect does not reflect a general neurohypophyseal hormone release. Expand
Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats
TLDR
It is suggested that chronic, but not acute, exposure to fluoxetine decreases 5-HT1A receptor function, which is not seen in rats chronically exposed to DMI. Expand
Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations.
TLDR
The data suggest that stimulation of 5-HT1C receptors induces excessive grooming, penile erection and increased oxytocin secretion, and Stimulation of5-HT2 receptors causes a further increase in plasma oxytoc in concentration, but inhibits both behavioral responses. Expand
Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
TLDR
Chronic treatment with both fluoxetine and DMI produced a potentiation in most hormone responses to the 5-HT agonists (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane HCl (DOI) and MK-212, although there were several differences in individual hormone responses. Expand
The oxytocin receptor antagonist 1-deamino-2-d-Tyr-(OEt)-4-Thr-8-Orn-oxytocin inhibits effects of the 5-HT1A receptor agonist 8-OH-DPAT on plasma levels of insulin, cholecystokinin and somatostatin
TLDR
The effect on the release of insulin, CCK and somatostatin induced by the 5 HT1A receptor agonist 8-OH-DPAT may be mediated by an oxytocinergic activation of a vagal mechanism. Expand
Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats.
TLDR
Evidence is provided that enhanced serotonergic transmission stimulates oxytocin secretion and that 5-HT2 receptors contribute to this effect. Expand
Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
TLDR
It was found that (-)-pindolol elicited a clearcut, selective, dose-dependent and stereospecific reduction of brain 5-HT synthesis rate, and the possibility is considered that, in addition to its beta-adrenergic properties, (--pINDolol is a mixed agonist-antagonist at central 5- HT receptors. Expand
1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.
TLDR
It is concluded that mCPBG is a potent, high affinity 5-HT3 receptor agonist. Expand
Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo
TLDR
The results, together with previous lesion studies, suggest that vagal CCK-A receptors in the periphery mediate the activation of the oxytocinergic pathway in vivo. Expand
The 5‐HT1B Receptors
TLDR
The development of selective 5-HT1B receptor agonists and antagonists will be a key step in defining the physiological role of this receptor site in the brain and periphery of the mouse and rat although it must be realized that these compounds, if they are developed, are unlikely to have functional effects in man since the 5- HT1B recognition site is absent in the human CNS. Expand
...
1
2
3
4
...